Checkpoint Therapeutics I... (CKPT)
NASDAQ: CKPT
· Real-Time Price · USD
4.26
0.00 (0.00%)
At close: May 29, 2025, 3:59 PM
Checkpoint Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 33.04M | 6.6M | 4.7M | 4.95M | 11.24M | 4.93M | 1.77M | 7.42M | 4.85M | 12.07M | 20.48M | 30.89M | 41.48M | 54.73M | 60.2M | 65.12M | 60.03M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | 41K | n/a | n/a | 31K | 31K | 35K | 73K | 48K | 18K | 52K | 17K | 29K | 155K | 68K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.12M | 867K | 476K | 678K | 734K | 450K | 415K | 886K | 1.01M | 1.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 34.16M | 7.47M | 5.18M | 5.67M | 11.97M | 5.38M | 2.22M | 8.34M | 5.9M | 13.29M | 21.62M | 32.08M | 42.91M | 55.73M | 60.97M | 66.12M | 61.43M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Assets | 34.16M | 7.47M | 5.18M | 5.67M | 11.97M | 5.38M | 2.22M | 8.34M | 5.9M | 13.29M | 21.62M | 32.08M | 42.91M | 55.73M | 60.97M | 66.12M | 61.43M |
Account Payables | n/a | 6.09M | 7.89M | 10.84M | 11.92M | 6.57M | 7.96M | 8.06M | 14.14M | 11.54M | 13.05M | 12.58M | 9.86M | 16.14M | 7.81M | 5.08M | 3.53M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 17.87M | 2.08M | 1.23M | 9.81M | 708K | 1.33M | 2.35M | 6.7M | 3.92M | 11.45M | 369K | 349K | 297K | 233K | 282K | 201K | 374K |
Total Current Liabilities | 17.87M | 20.1M | 17.77M | 21.42M | 22.23M | 18.43M | 21.26M | 31.61M | 28.07M | 32.77M | 22.95M | 24.62M | 22.69M | 25.98M | 13M | 9.25M | 7.25M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20.3M | n/a | n/a | 10.87M | n/a | n/a | n/a | n/a |
Total Liabilities | 17.87M | 20.1M | 17.77M | 21.42M | 22.23M | 18.43M | 21.26M | 31.61M | 28.07M | 32.77M | 22.95M | 24.62M | 22.69M | 25.98M | 13M | 9.25M | 7.25M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 268K | 5K | 5K | 4K | 4K | 3K | 2K | 2K | 1K | 1K | 10K | 9K | 9K | 1K | 9K | 9K | 8K |
Retained Earnings | -381.79M | -370.57M | -341.67M | -331.95M | -325.28M | -314.33M | -295.2M | -289.48M | -272.96M | -262.49M | -241.46M | -230.85M | -216.71M | -199.86M | -170.11M | -158.84M | -149.7M |
Comprehensive Income | n/a | n/a | n/a | n/a | 3.42M | 3.42M | n/a | n/a | n/a | 1.89M | n/a | n/a | n/a | 6.6M | n/a | n/a | n/a |
Shareholders Equity | 16.3M | -12.63M | -12.59M | -15.75M | -10.25M | -13.05M | -19.04M | -23.27M | -22.18M | -19.48M | -1.33M | 7.46M | 20.22M | 29.75M | 47.97M | 56.87M | 54.17M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |